The JSE was little changed on Monday, with its global peers mixed as investors weigh prospects of a vaccine rollout and the latest US stimulus development bill against the effects of the Covid-19 pandemic.

The first deliveries of Pfizer-BioNTech vaccines are scheduled for Monday, while a bipartisan group of legislators will unveil a $908bn pandemic relief bill the same day, though there is no guarantee the Congress will pass it, a key negotiator said...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.